The altered expression of MHC-class II determinants on monocytes of cancer patients
- PMID: 2458182
- PMCID: PMC11038092
- DOI: 10.1007/BF00200023
The altered expression of MHC-class II determinants on monocytes of cancer patients
Abstract
The expression of MHC class II determinants Ia.7 (detected by cross reactive mouse anti-Iak antibody) and HLA-DR on monocytes (MO) of gastric and colorectal cancer patients was examined. An increased proportion of MO bearing the Ia.7 determinant was found, while the number of MO expressing DR was not elevated. In gastric cancer patients the increased expression of the Ia.7 determinant was most pronounced in advanced cancer (stage IVA and IVB). The increased expression of this determinant was related to the presence of the tumour as the number of MO expressing Ia.7 decreased 6 months following surgical resection of the tumour. Further, the increased expression of Ia.7 on MO correlated with the tumour infiltration of the serosa. The Ia.7 determinants were mainly expressed on MO which also expressed the receptor for the Fc part of immunoglobulin. Immunostaining in cellular infiltrates surrounding the tumour revealed that Ia.7+ macrophages (MO) were more numerous than in normal gastric mucosa and severe chronic gastritis and were mostly present in close proximity to tumour cells, while DR+MO were mainly localized within the stromal tissue of the tumour and their number was not increased in cancer infiltrates. These observations indicate that the Ia.7+ subpopulation of MO may be involved in the anti-tumour response of the host.
Similar articles
-
Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.J Clin Invest. 1983 Sep;72(3):1124-9. doi: 10.1172/JCI111037. J Clin Invest. 1983. PMID: 6193142 Free PMC article.
-
The role of MHC class II antigenic determinants in the function of human antigen binding T8+ cells, monocytes and helper and suppressor factors.Clin Exp Immunol. 1984 Jun;56(3):683-93. Clin Exp Immunol. 1984. PMID: 6204796 Free PMC article.
-
Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.Tissue Antigens. 1986 Nov;28(5):288-97. doi: 10.1111/j.1399-0039.1986.tb00498.x. Tissue Antigens. 1986. PMID: 2435017
-
Non-co-ordinate expression of HLA-DR antigens and invariant chain.Immunology. 1988 Mar;63(3):551-3. Immunology. 1988. PMID: 3280476 Free PMC article.
-
[HLA-DR antigens: cellular expression and molecular structure].Ann Immunol (Paris). 1982 Sep-Oct;133D(2):155-69. Ann Immunol (Paris). 1982. PMID: 6187269 Review. French.
Cited by
-
Recombinant interferon gamma up-regulates in vivo and down-regulates in vitro monocyte CD14 antigen expression in cancer patients.Cancer Immunol Immunother. 1990;31(5):292-6. doi: 10.1007/BF01740937. Cancer Immunol Immunother. 1990. PMID: 1695870 Free PMC article.
References
-
- Allen C, Hogg N. Elevation of infiltrating mononuclear phagocytes in human colorectal tumors. J Natl Cancer Inst. 1987;78:465. - PubMed
-
- Allen CA, Hogg N. Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes. Cancer Res. 1987;47:2919. - PubMed
-
- Basham TY, Merigan TC. Recombinant interferon gamma increases HLA-DR synthesis and expression. J Immunol. 1983;130:1492. - PubMed
-
- Brown R, Wolman M. Differentiation of macrophages for Lewis lung carcinoma tumour cells in tissue sections by their alpha-naphthyl butyrate esterase activity. Histochem J. 1981;13:975. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials